| Alaa Samaro, RPH | |
|
119 W 6th Ave, El Dorado, KS 67042-1934 | |
| (316) 519-2614 | |
| Not Available |
| Full Name | Alaa Samaro |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 119 W 6th Ave, El Dorado, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033610217 | NPI | - | NPPES |
| 1100754 | Other | KS | NABP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1100754 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alaa Samaro, RPH 119 W 6th Ave, El Dorado, KS 67042-1934 Ph: () - | Alaa Samaro, RPH 119 W 6th Ave, El Dorado, KS 67042-1934 Ph: (316) 519-2614 |
News Archive
CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday, September 22, 2010. The lecture, entitled "Status of the CID Cre8 polymer-free DES program", will be delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention at Instituto Dante Pazzanese, in Sao Paulo Brazil, and will be part of the session "The Next Generation DES, Polymer-Free".
The International Association of Eating Disorders Professionals (iaedp) kicks off its 27th annual Symposium March 21-24 at the Westin Lake Las Vegas Resort and Spa and will feature five nationally recognized professionals addressing new treatments and research concerning eating disorders.
Conatus Pharmaceuticals Inc. announced today that Conatus acquired the Idun Pharmaceuticals subsidiary of Pfizer Inc. Financial terms were not disclosed. Conatus Pharmaceuticals is a privately-held drug development company focused on liver disease and oncology.
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the 725th event (patient death) has been reached in its pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy.
Memorial Blood Centers (MBC), a national leader in transfusion medicine, today announced the receipt of a $50,000 grant from The Foundation for America's Blood Centers (FABC) that will further research into blood donor safety.
› Verified 9 days ago
Martha Jean Tymony, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 S Village Rd, El Dorado, KS 67042 Phone: 316-322-8901 | |
Austin Michael Chinberg, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 720 W Central Ave, El Dorado, KS 67042 Phone: 316-321-3300 | |
Steven Vuong, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 N Main St, El Dorado, KS 67042 Phone: 316-321-0318 Fax: 316-321-8810 | |
Jacob Milbradt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 N Vine St, El Dorado, KS 67042 Phone: 316-321-5330 Fax: 316-321-1254 | |
Dr. Luanna Thomas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 720 W Central Ave, El Dorado, KS 67042 Phone: 316-322-4560 | |
Rachel Markovich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 N Main St, El Dorado, KS 67042 Phone: 316-321-0318 |